Novo Nordisk sues 3 compounding pharmacies over Ozempic copycats

Novo Nordisk filed lawsuits against three compounding pharmacies in Florida on July 6, accusing them of illegally compounding forms of its popular Type 2 diabetes drug Ozempic.